Learn about the development and manufacturing of the xenograft-expanded FANG vaccine, advancing personalized cancer treatment.

XENOGRAFT EXPANDED FANG AUTOLOGOUS TUMOR CELL VACCINE DEVELOPMENT AND MANUFACTURING FOR CLINICAL USE

Monday, July 26, 2010

Read the Story Here

Related Posts

Discover more posts like this.

A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma

Sep 5, 2024

ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab- Paclitaxel in Patients with Advanced Solid Tumors

Sep 5, 2024

Preliminary Clinical Activity of RMC-6236, a First-in-Class, RAS-Selective, Tri-Complex RASMULTI(ON) Inhibitor in Patients with KRAS-Mutant Pancreatic Ductal Adenocarcinoma (PDAC) and Non-Small Cell Lung Cancer (NSCLC)

Aug 23, 2024

Dr. Minal Barve
See All Posts